Galmed Pharmaceuticals Statistics
Total Valuation
GLMD has a market cap or net worth of $3.55 million. The enterprise value is -$11.79 million.
| Market Cap | 3.55M |
| Enterprise Value | -11.79M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025, before market open.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GLMD has 2.26 million shares outstanding. The number of shares has increased by 303.31% in one year.
| Current Share Class | 2.26M |
| Shares Outstanding | 2.26M |
| Shares Change (YoY) | +303.31% |
| Shares Change (QoQ) | +93.73% |
| Owned by Insiders (%) | 2.89% |
| Owned by Institutions (%) | 2.06% |
| Float | 2.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | 0.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.42
| Current Ratio | 7.42 |
| Quick Ratio | 7.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.29 |
Financial Efficiency
Return on equity (ROE) is -49.77% and return on invested capital (ROIC) is -25.94%.
| Return on Equity (ROE) | -49.77% |
| Return on Assets (ROA) | -22.34% |
| Return on Invested Capital (ROIC) | -25.94% |
| Return on Capital Employed (ROCE) | -38.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.25M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.29% in the last 52 weeks. The beta is 0.70, so GLMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -67.29% |
| 50-Day Moving Average | 1.87 |
| 200-Day Moving Average | 3.24 |
| Relative Strength Index (RSI) | 48.71 |
| Average Volume (20 Days) | 105,975 |
Short Selling Information
| Short Interest | 96,430 |
| Short Previous Month | 68,161 |
| Short % of Shares Out | 4.40% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.28M |
| Pretax Income | -6.36M |
| Net Income | -7.52M |
| EBITDA | -6.20M |
| EBIT | -6.28M |
| Earnings Per Share (EPS) | -$8.08 |
Balance Sheet
The company has $15.33 million in cash and n/a in debt, giving a net cash position of $15.33 million or $6.79 per share.
| Cash & Cash Equivalents | 15.33M |
| Total Debt | n/a |
| Net Cash | 15.33M |
| Net Cash Per Share | $6.79 |
| Equity (Book Value) | 16.33M |
| Book Value Per Share | 9.81 |
| Working Capital | 13.95M |
Cash Flow
| Operating Cash Flow | -5.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.88M |
| FCF Per Share | -$2.60 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -303.31% |
| Shareholder Yield | n/a |
| Earnings Yield | -212.04% |
| FCF Yield | -165.86% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 30, 2024. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |